Medtronic Infection Control delivers site-specific therapy by commercializing proprietary, implantable medical-pharmaceutical combination devices for multiple surgical markets. The Medtronic Infection Control product line is focused on a singular goal: creating unique, cost-effective solutions that address Surgical Site Infections (SSIs) and inflammatory tissue-reaction associated with implanted medical devices. The TYRX™ Absorbable Antibacterial Envelope, designed for device stabilization and infection reduction, is commercially available in over 40 countries including the US, Canada, and Europe.
